Animal Pain Management Market Definition
The global animal pain management market is expected to witness the growth throughout the forecasted period due to the rising swelling pain in animals due to osteoarthritis and growing pain related disorders in pet animals. Animal pain management deals with the pain which is an unpleasant sensory and emotional experience of the animal where it is associated with the inflammation. The pain in animals is even more difficult to quantify and qualify, to manage the pain number of pain-relieving drugs and therapies are used in pets and other animals.
The market study is broken down, by Application (Veterinary Care Center and Veterinary Hospital) and major geographies with country level splits.
Boehringer Ingelheim (Germany), Merck Animal (United States), Elanco Animal Health (United States), Bayer Animal Health (Germany), Zoetis Inc. (United States), Virbac (France), Ceva Sante Animale (France), Vetoquinol S.A. (France), Bimeda, Inc. (Ireland) and Chanelle Pharma Group (Ireland) are some of the key players that are part of study coverage.
AdvanceMarketAnalytics has segmented the market of Global Animal Pain Management market by Type, Application and Region.
On the basis of geography, the market of Animal Pain Management has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Analgesics, the sub-segment i.e. Non-opioids will boost the Animal Pain Management market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Cause, the sub-segment i.e. Osteoarthritis will boost the Animal Pain Management market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by End User, the sub-segment i.e. Pets will boost the Animal Pain Management market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
On 26th April 2019, Elanco Animal Health announced an agreement to acquire Aratana Therapeutics a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, and developer of the first-of-its-kind canine NSAID for osteoarthritis, Gallipran. Elanco has also signed a development and commercialization agreement with VetDC for Tanovea-CA1, the first U.S. Food and Drug Administration (FDA) conditionally approved canine lymphoma treatment.
"FDA has approved several nonsteroidal anti-inflammatory drugs for dogs to control pain and inflammation associated with osteoarthritis, and to control pain and inflammation after soft tissue and orthopedic surgery. [Orthopedic pertains to bones and muscles; soft tissue is everything else. Repairing a dog’s torn ACL (anterior cruciate ligament) in her knee is an orthopedic surgery; removing a ball from a dog’s stomach is a soft tissue surgery.] The labels for an FDA-approved NSAID for dogs or cats is written specifically for that species. The label includes all the information veterinarians need to use the drug safely and effectively in that species."
- Advances in Animal Pain Management Technology
- RIsing Animal Pain Management Hospitals and Centers
- Growing Pain Related Disorders in Pet Animals
- Rise in Swelling in Animals Associated with Osteoarthritis
- Increasing Number of Certified Animal Pain Management Professionals
- Continuous Research and Development in Animal Pain Management
- Overdose of Analgesics in Animal for Pain Management Might Effects the Animal Health Adversely
- Stringent Regulatory Guidelines on Animal Pain Management
Key Target Audience
Animal Pain Management Service Providers, Animal Pain Management Hospitals, Animal Pain Management Industry Associations, Research and Development Institutes, Potential Investors, Regulatory Bodies and Others
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from total available market.
Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase